Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2022-10-28 00:00:00 ET · period of report 2022-10-26 · accession 0001104659-22-112522 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 | 2022-10-26 | FBIO | Jin David | CFO | A - Grant | $0.00 | +1.35M | 1.40M | +2,823% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.001 | 2022-10-26 | A | A | 1,350,000 | $0.00 | 1,397,829 | D | — | — | (F1) Represents an award of 1,350,000 restricted stock units which will vest in 48 equal monthly installments after the grant date, October 26, 2022. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Corporate Transaction (as defined in the Fortress Biotech, Inc. 2013 Stock Incentive Plan); the amount will be distributed in the form of the Issuer's common stock. (F2) The total holdings include 1,350,000 shares underlying restricted stock units. |